The	O
immunophenotype	O
shows	O
overlapping	O
features	O
between	O
.	O
hepatocellular	O
carcinoma	O
and	O
cholangiocarcinoma	O
;	O
however	O
,	O
given	O
.	O
the	O
strong	O
HepPar1	O
staining	O
,	O
a	O
poorly	O
differentiated	O
.	O
hepatocellular	O
carcinoma	O
is	O
favored	O
.	O
